Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Pediatr Blood Cancer. 2021 Apr 6;68(7):e28988. doi: 10.1002/pbc.28988

Table 1.

List of Treatment Exposures Included in Multivariable Models for Each Health Condition

Health Conditiona Condition-Specific Treatment Exposuresc
Cardiac chest radiation, anthracyclines, alkylating agents (heavy metal, classic)
Pulmonary chest radiation, bleomycin, alkylating agents (classic)
Endocrineb Cranial and neck radiation, corticosteroids, methotrexate
Renal abdominal radiation, ifosfamide, alkylating agents (heavy metal)
Neurology cranial radiation, high dose intravenous methotrexate, intrathecal methotrexate/cytarabine
Gastrointestinal/Hepatic neck, chest, and abdominal radiation
Musculoskeletal cranial, chest, and abdominal radiation, methotrexate, corticosteroids,
Anxiety/Depression cranial radiation, intrathecal methotrexate/cytarabine, high dose intravenous methotrexate, corticosteroids
a

in addition to treatment exposures, all models were adjusted for the following covariates: age at evaluation, age at diagnosis, sex, race/ethnicity, body mass index (BMI), and physical inactivity

b

BMI removed as a covariate in the endocrine models because obesity is an outcome, grade 2 obesity excluded

c

treatment exposures classified as yes/no variables